Logo der Universität Basel

Research Database / FORSCHUNGSDATENBANK 
PRINTDOC
 
Publication 4599077 | Verified
 

Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Utility and risk of dermatologic medications during the COVID-19 pandemic
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 4599077
Author(s) Goldust, Mohamad; Hartmann, Karin; Abdelmaksoud, Ayman; Navarini, Alexander A.
Author(s) at UniBasel Hartmann, Karin
Year 2020
Title Utility and risk of dermatologic medications during the COVID-19 pandemic
Journal Dermatologic Therapy
Pages / Article-Number e13833
Keywords COVID-19; Dermatologic medications; Pandemic
Abstract In the era of staggering speed in development of the novel coronavirus (CoV) pandemic (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2), we have reviewed the dermatologists' tools at hand for their utility (and potential risks) in patients affected by COVID-19. This review aims to shed light on the anti-viral and pro-viral potential of drugs routinely used in dermatology to modulate COVID-19. The literature search included peer-reviewed articles published in English language (clinical trials or scientific reviews). Studies were identified by searching electronic databases (MEDLINE and PubMed) from January 1990 to March 2020 and by reference lists of respective articles. Somewhat to our surprise, we have found that several of our drugs widely used in dermatology have antiviral potential. On the other hand, we also frequently use immunosuppressive drugs in our dermatologic patients that potentially pose them at increased risk for COVID-19. This article is protected by copyright. All rights reserved.
Publisher Wiley
ISSN/ISBN 1396-0296 ; 1529-8019
URL https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7323423/
edoc-URL https://edoc.unibas.ch/77477/
Full Text on edoc No
Digital Object Identifier DOI 10.1111/dth.13833
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/32537852
ISI-Number WOS:000555749500001
Document type (ISI) Journal Article, Review
 
   

MCSS v5.8 PRO. 0.352 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
18/04/2024